Abstract

The human calcium-sensing receptor gene (CASR) has 8 exons, and localizes to chromosome 3q. Exons 1A and 1B encode alternative 5′-untranslated regions (UTRs) that splice to exon 2 encoding the AUG initiation codon. Exons 2–7 encode the CaSR protein of 1078 amino acids. Promoter P1 has TATA and CCAAT boxes upstream of exon 1A, and promoter P2 has Sp1/3 motifs at the start site of exon 1B. Exon 1A transcripts from the P1 promoter are reduced in parathyroid tumors and colon carcinomas. Studies of colon carcinomas and neuroblastomas have emphasized the importance of epigenetic changes—promoter methylation of the GC-rich P2 promoter, histone acetylation—as well as involvement of microRNAs in bringing about CASR gene silencing and reduced CaSR expression. Functional cis-elements in the CASR promoters responsive to 1,25-dihydroxyvitamin D [1,25(OH)2D], proinflammatory cytokines, and the transcription factor glial cells missing-2 (GCM2) have been characterized. Reduced levels of CaSR and reduced responsiveness to active vitamin D in parathyroid neoplasia and colon carcinoma may blunt the “tumor suppressor” activity of the CaSR. The hypocalcemia of critically ill patients with burn injury or sepsis is associated with CASR gene upregulation by TNF-alpha and IL-1beta via kappaB elements, and by IL-6 via Stat1/3 and Sp1/3 elements in the CASR gene promoters, respectively. The CASR is transactivated by GCM2—the expression of which is essential for parathyroid gland development. Hyperactive forms of GCM2 may contribute to later parathyroid hyperactivity or tumorigenesis. The expression of the CaSR—the calciostat—is regulated physiologically and pathophysiologically at the gene level.

Highlights

  • Experimental Therapeutics and Metabolism, McGill University Health Centre-Research Institute, Departments of Medicine, Physiology, and Human Genetics, McGill University, Montréal, QC, Canada

  • The hypocalcemia of critically ill patients with burn injury or sepsis is associated with calcium-sensing receptor gene (CASR) gene upregulation by TNF-alpha and IL-1beta via kappaB elements, and by IL-6 via Stat1/3 and Sp1/3 elements in the CASR gene promoters, respectively

  • These results suggested that P1 activity was reduced in parathyroid adenomas and is qualitatively in agreement with several studies showing a decrease in CaSR mRNA and protein expression in parathyroid adenomas relative to normal glands (Kifor et al, 1996; Farnebo et al, 1997; Gogusev et al, 1997; Cetani et al, 2000; Corbetta et al, 2000)

Read more

Summary

THE CASR GENE

The single-copy CASR gene that maps to human 3q13.3-21 encodes a Class C G protein-coupled receptor family member (Pollak et al, 1993; Janicic et al, 1995). The T-cell antigen CD86 gene lies upstream and the cysteine protease inhibitor CSTA gene downstream of the CASR gene and all are transcribed in the same 5′ to 3′ direction. The CASR gene has eight exons and spans ∼100-kb (Yun et al, 2007) (Figure 1). Exons 2 to 7 encode the CaSR protein of 1078 aa (GenBank #U20759). Two different polyadenylation signal sequences within exon 7 may be used, to generate either a short (177-nucleotide) or a long (1304nucleotide) 3′-untranslated region (UTR) (Aida et al, 1995; Garrett et al, 1995). Exon 2 encodes 242 nucleotides of the 5′-UTR upstream of the ATG translation initiation codon.

CASR Gene Expression
Alternative Transcripts
Transcriptional Control of the CASR Gene
Vitamin D
Proinflammatory Cytokines
Other Considerations
CASR Expression and Kidney Stones
CASR and Epigenetic Modification
CaSR And MicroRNAs
Findings
PERSPECTIVES AND CONCLUSIONS
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call